Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 9:15:1449133.
doi: 10.3389/fmicb.2024.1449133. eCollection 2024.

Perspective: on the future of fecal microbiota transplantation

Olaf F A Larsen  1 , Robert J M Brummer  2
Affiliations

Perspective: on the future of fecal microbiota transplantation

Olaf F A Larsen et al. Front Microbiol. .

Abstract

Fecal Microbiota Transplantation (FMT) has shown to possess impressive potential benefit for a wide range of clinical indications. Due to its inherent safety issues and efficacy constraints, the use of personalized FMT analogs could be a promising avenue. The development of such analogs will require a detailed understanding of their functionality, encompassing not only microbe-host interactions of the microbial taxa that are involved, but also of the ecological dimensions of the analogs and an overview of the gastrointestinal sites where these relevant microbial interactions take place. Moreover, characterization of taxa that have been lost due to diminished exposure to beneficial microbes, as a consequence of Western lifestyle, may lead to creation of future FMT analogs with the capacity to restore functionalities that we have lost.

Keywords: One Health; analogs; fecal microbiota transplantation; gut microbiota; personalized; probiotics.

PubMed Disclaimer

Conflict of interest statement

OL is Senior Manager Science at Yakult Nederland B. V. RB is also a member of the Scientific Advisory Board of The Akkermansia Company.

References

    1. Bachmann R., van Hul M., Baldin P., Léonard D., Delzenne N. M., Belzer C., et al. . (2022). Akkermansia muciniphila reduces peritonitis and improves intestinal tissue wound healing after a colonic transmural defect by a MyD88-dependent mechanism. Cells 11:2666. doi: 10.3390/cells11172666, PMID: - DOI - PMC - PubMed
    1. Banerjee S., Schlaeppi K., van der Heijden M. G. A. (2018). Keystone taxa as drivers of microbiome structure and functioning. Nat. Rev. Microbiol. 16, 567–576. doi: 10.1038/s41579-018-0024-1 - DOI - PubMed
    1. Cao Z., Sugimura N., Burgermeister E., Ebert M. P., Zuo T., Lan P. (2022). The gut virome: a new microbiome component in health and disease. EBioMedicine 81:104113. doi: 10.1016/j.ebiom.2022.104113, PMID: - DOI - PMC - PubMed
    1. Catlett J. L., Carr S., Cashman M., Smith M. D., Walter M., Sakkaff Z., et al. . (2022). Metabolic synergy between human symbionts Bacteroides and Methanobrevibacter. Microbiol. Spectr. 10, e01067–e01022. doi: 10.1128/spectrum.01067-22 - DOI - PMC - PubMed
    1. Chibani C. M., Mahnert A., Borrel G., Almeida A., Werner A., Brugère J.-F., et al. . (2022). A catalogue of 1,167 genomes from the human gut archaeome. Nat. Microbiol. 7, 48–61. doi: 10.1038/s41564-021-01020-9 - DOI - PMC - PubMed

LinkOut - more resources